New RedThread Research Report Helps L&D Teams Maximize Frontline Impact with Limited Resources
New report introduces a practical framework to help organizations target frontline development for core business functions, performance, and future readiness. WOODSIDE,... Read more.
QuickLogic Delivers eFPGA Hard IP for Intel 18A Based Test Chip
SAN JOSE, Calif., April 28, 2025 /PRNewswire/ — QuickLogic Corporation (NASDAQ: QUIK), a leading developer of embedded FPGA (eFPGA) Hard IP and User Tools,... Read more.
Marriott International to Acquire the citizenM Brand
Acquisition Supports Company’s Growth in Innovative Lifestyle Offerings BETHESDA, Md., April 28, 2025 /PRNewswire/ — Today, Marriott International (Nasdaq:... Read more.
Rockwell Automation Unveils Powerful New Service to Detect and Respond to OT Cyber Threats
New offering delivers 24/7 real-time threat detection and response to combat risingcybersecurity risks in operational technology environments MILWAUKEE, April 28,... Read more.
GetYourGuide Elevates Experiences with New Tools, Previews Shows & Events
The #1 experience app releases suite of features to help experience operators “step into the spotlight” with a global audience NEW YORK and BERLIN, April... Read more.
Nova Releases 2025 Sustainability Insight Report
REHOVOT, Israel, April 28, 2025 /PRNewswire/ — Nova (NASDAQ: NVMI), a leading innovator and a key provider of advanced metrology and process control solutions... Read more.
HERVolution Appoints Dr. Tine Gaziel as CMO to Advance Dark Genome-Targeting Immune Therapy into the Clinic
As an experienced and thoughtful medical executive, Dr. Gaziel directed key clinical development and research at Eli Lilly, Y-mAbs Therapeutics, and Genmab In her... Read more.
Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference
AUSTIN, Texas, April 28, 2025 /PRNewswire/ — Rein Therapeutics (“Rein”) (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline... Read more.
Opera Reports 40% Revenue Growth in the First Quarter 2025, Raises Full-Year Guidance Ranges for Both Revenue and Adjusted EBITDA
Revenue accelerated further to 40% year-over-year growth and $142.7 million in the quarter, far exceeding the guidance range Adjusted EBITDA of $32.3 million, a... Read more.
JCET Reports Q1 2025 Revenue Growth of 36.4% and Net Profit Growth of 50.4%
Q1 2025 Financial Highlights: Q1 revenue of RMB 9.34 billion, a 36.4% increase year-on-year, marking a record high for the same period. Q1 net profit attributable... Read more.